On March 24, Dr. Oliver Röhl, Department Head of Microbiology at GBA GROUP and M. Sc. Sarah Henze, Team Leader "Expertises for Indoor Hygiene" will participate in the mold conference in Berlin and will also be present with a booth in the atrium of the Mercure Hotel (MOA Berlin).

ABF is proud to introduce Dinka Vukovic as its new Head of Business Development. Dinka brings insight and depth to this position, having served as ABF Head of Proposal and Competence Management for worldwide clinical trials for more than 2 years already.

Dinka is a trained pharmacist with 5 years of professional expertise in this field. She has also completed post graduate studies in Pharmaceutical Quality Management.

“I am thrilled to take over this new position and connect with our existing and future clients within Europe and globally”, said Dinka. "Additionally I am looking forward to all the clinical studies ABF can support with its services. As we say at GBA Group Pharma, your challenges require smart solutions.”

We are proud to announce, that LKF is since Feb. 2022 member of Life Science Nord. Life Science Nord is the regional industry network for medical technology, biotechnology and pharma for the states of Hamburg and Schleswig-Holstein. With some 500 companies, universities and research institutes and more than 260 active members, Life Science Nord is an important economic and innovation factor and a key element of the policy of both federal states.

Molds often grow covertly and as a result of prolonged elevated moisture levels in the affected material. In order to trace the exact cause of mold damage, the molds present must be determined at the species and genus level. This requires a material suspension and examination of the culturable molds.

New Regulation (EU) 2022/85 amending Annex II to Regulation (EC) No 396/2005 as regards maximum residue levels for flonicamid in or on certain products. These changes will apply from 02.10.2022.